Randall Shultz, Chief Technology Officer at Arcadia Biosciences, Inc. (RKDA), bought 700 shares at $3.16 ($2K) on 2020-08-03, disclosed to the SEC on 2021-01-25.
Open-market purchase of $2k RKDA by Chief Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.